Abingdon Health Plc

ABDX

GB00BLF79J41

Medical Equipment, Supplies & Distribution

Delayed London S.E. Other stock markets 12:45:31 30/04/2024 BST			5-day change	1st Jan Change
9.856 ^GBX	-1.44%		-6.13%	-10.40%

03-25	Peel Hunt's RetailBook raises GBP2.5 million	AN
03-25	Abingdon Health Completes Design Freeze for STD Self-Tests	MT

Abingdon Health plc Announces Earnings Guidance for the Fiscal Year 2021

April 27, 2021 at 07:00 am

Abingdon Health Plc announced earnings guidance for the fiscal year 2021. For the year, the company now anticipates FY21 revenue will be in the range of £11.4 million to £17.0 million.

Latest news about Abingdon Health Plc

Peel Hunt's RetailBook raises GBP2.5 million	03-25	AN
Abingdon Health Completes Design Freeze for STD Self-Tests	03-25	MT
Abingdon Health to Provide Rapid Self-tests to Boots	03-20	MT
Abingdon Health strikes deal amidst upswing in self testing market	03-20	AN
AIM WINNERS & LOSERS: Abingdon Health rises on Boots agreement	03-20	AN
EARNINGS AND TRADING: Smarttech247 and Beeks in deal boosts	03-14	AN
AIM WINNERS & LOSERS: Smartspace backs Sign In bid; Abingdon jumps	03-14	AN
London stocks tread water with US data to come	03-14	AN
ABINGDON HEALTH PLC: BOARD EXPECTS THAT H2 REVENUE WILL BE SIGN…	03-14	RE
Abingdon Health plc Provides Earnings Guidance for the Second Half and Full Fiscal Year 2024	03-14	CI
Abingdon Health Plc Reports Earnings Results for the Half Year Ended December 31, 2023	03-14	CI
Abingdon Health shares down despite decent interim results	01-11	AN
Abingdon Health Plc Announces Promotion of Laura Towse as Group Financial Controller	01-11	CI
Abingdon Health plc Announces Resignation of Andrew Feather as Interim Finance Director	01-11	CI
Abingdon Health Plc Reports Revenue Results for the Six Months Ended December 31, 2023	01-11	CI
Abingdon expects higher half-year revenue	12-15	AN
Stocks edge higher ahead of slew of PMIs	12-15	AN
FTSE 100 Closes Up on Tech Earnings Expectations, Easing Bond Yields	24/10/23	DJ
Abingdon Health appoints Feather as new interim finance director	24/10/23	AN
Abingdon Health Names Interim Finance Director	24/10/23	MT
Abingdon Health Plc Announces Executive Changes	24/10/23	CI
FTSE 100 Closes Down 1.1% on Middle East Tensions	18/10/23	DJ
Abingdon Health finance chief resigns, seeks interim hire	18/10/23	AN
Abingdon Health CFO Plans Exit; Stock Drops	18/10/23	MT
Abingdon Health plc Announces Resignation of Melanie Ross as Director	18/10/23	CI

Abingdon Health plc is a lateral flow contract development and manufacturing organization (CDMO). The Company develops, manufactures, and distributes diagnostic devices and provides consultancy services to businesses in the diagnostics sector. Its segments include Product sales, Contract manufacturing, and Contract development. Its customer base across industry sectors includes clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available.

Sector

Medical Equipment, Supplies & Distribution

Calendar

13/11/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
ABINGDON HEALTH PLC	-10.40%	38.65M
BIOMÉRIEUX	+0.70%	12.95B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-7.57%	7.84B
DIASORIN S.P.A.	+1.57%	5.5B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.93%	4.61B
LANTHEUS HOLDINGS, INC.	+8.48%	4.61B
10X GENOMICS, INC.	-49.25%	3.4B
ANDON HEALTH CO., LTD.	+9.21%	2.66B
VITROLIFE AB	-14.59%	2.08B
MYRIAD GENETICS, INC.	+3.45%	1.79B